Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc. (BBIO), sold 55,185 shares at $66.84 ($3.7M) on 2025-11-17, disclosed to the SEC on 2025-11-18.
Scheduled sale ($3.7M) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.39 | 21,317 | $1.4M | 38.6% |
| 2 | $66.19 | 9,978 | $660K | 18.0% |
| 3 | $66.19 | 9,978 | $660K | 18.0% |
| 4 | $66.84 | 6,956 | $465K | 12.7% |
| 5 | $66.84 | 6,956 | $465K | 12.7% |
| Total | $66.43 avg | 55,185 |
| $3.7M |
| 100% |
| Filing → |
| BBIO | SELL | 2025-08-22 | $4.2M | — | Filing → |
| BBIO | SELL | 2025-08-19 | $1.7M | — | Filing → |